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Abstract
Background and Purpose—Atrial fibrillation (AF) has been associated with cognitive decline
independant of stroke, suggesting additional effects of AF on the brain. We aimed to assess the
association between AF and brain function and structure in a general elderly population.
Methods—This is a cross-sectional analysis on 4251 non-demented participants (mean age 76 ±
5 years) in the population-based AGES-Reykjavik Study. Medical record data were collected on
the presence, subtype and time from first diagnosis of AF; 330 participants had AF. Brain volume
measurements, adjusted for intracranial volume, and presence of cerebral infarcts were determined
with MRI. Memory, speed of processing and executive function composites were calculated from
a cognitive test battery. In a multivariable linear regression model, adjustments were made for
demographic, cardiovascular risk factors and cerebral infarcts.
Results—Participants with AF had lower total brain volume compared to those without AF
(p<0.001). The association was stronger with persistent/permanent than paroxysmal AF and with
increased time from the first diagnosis of the disease. Of the brain tissue volumes, AF was
associated with lower volume of gray and white matter (p<0.001 and p=0.008 respectively) but
not of white matter hyperintesities (p=0.49). Participants with AF scored lower on tests on
memory.
Conclusions—AF is associated with smaller brain volume and the association is stronger with
increasing burden of the arrhythmia. These findings suggest that AF has a cumulative negative
effect on the brain independent of cerebral infarcts.
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Introduction
The number of individuals with AF is projected to triple in the next four decades (1). Data
have emerged showing that AF may be a risk factor for cognitive impairment and dementia
independent of stroke, indicating that the arrhythmia has additional adverse effects on the
brain (2-5). Brain atrophy, both of the gray and white matter, as well as increased white
matter hyperintesities have been associated with detriment of brain function but currently
there is limited data on AF and brain volume (6).
Three previous studies did not find a significant association between AF and total brain
atrophy (7-9). These studies did not report whether there was a difference between patients
with paroxysmal and permanent AF or whether the time from the first diagnosis of AF was
of any significance. They also did not report differences in specific brain tissue volumes.
Gaining a better understanding of the relationship between AF and brain structure might
prove useful for developing interventions to potentially delay the progression to dementia in
these patients.
The aim of this study was to examine the association between AF and brain measures on
MRI as well as cognitive function using data from the large population- based Age, Gene/
Environment Susceptibility-Reykjavik (AGES-Reykjavik) study. Furthermore the purpose
was to assess the significance of the duration and type of AF (paroxysmal versus persistent/
permanent) on these outcome measures.
Materials and methods
The AGES-Reykjavik Study was designed to investigate the genetic and environmental
factors contributing to clinical and subclinical disease at older age. The study is a
continuation of the Reykjavik Study, which was a total population study of men and women
born between 1907 and 1935 who were residents of the Greater Reykjavik area in 1967. The
study was a longitudinal study carried out from 1967 to 1994 that collected mid-life data on
cardiovascular traits (10-11). The AGES-Reykjavik cohort is a random recruitment of
survivors from the Reykjavik study. It included 5,764 subjects (2,438 men and 3,326
women), aged 67 to 93 years. From September 2002 to February 2006, new data were
collected at the research center: a questionnaire was administered, a clinical examination
was performed, and images were acquired of the brain, musculoskeletal system, body
composition, vasculature and heart. The study design and initial assessments of the cohort
have been described previously in more detail (12).
The AGES-Reykjavik Study has been approved by the Icelandic National Bioethics
Committee, which acts as the Institutional Review Board for the Icelandic Heart
Association, and by the Institutional Review Board for the Intramural Research Program of
the National Institute on Aging, National Institutes of Health, USA. Informed consent was
obtained from all participants
Ascertainment of Atrial Fibrillation
AF was identified by: reviewing hospital records and private physician's records for all
participants with the hospital discharge diagnosis codes for AF (ICD-9 code 427.9 or
ICD-10 code I48) from any hospital in Reykjavik from January 1st 1987 till the day of the
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study examination, and by reviewing a twelve lead electrocardiogram (ECG) performed
during the AGES-Reykjavik study comprehensive examination. Prolonged monitoring was
not performed. Using information from the participants aforementioned records and from
the study examination AF was classified as either paroxysmal or persistent/permanent
according to recently published guidelines (13). Those who only had AF that occurred less
than 4 weeks from open heart surgery were excluded. Duration of AF was calculated from
the date of first diagnosis of AF till the date of the study examination.
Potential Confounders
Age, sex, education level (primary/secondary/college or university), smoking status (never
smoker/ever smoker) and alcohol consumption (none or low (0-7 drinks/week)/moderate or
high (>7 drinks/week)) were assessed by a questionnaire. High depressive symptomatology
was classified as a score of 6 or greater on the 15-item Geriatric Depression Scale (14).
Body mass index (BMI) was calculated from measured height and weight.
Hypercholesterolemia was defined as total cholesterol level >6.0 mmol/L or current use of
lipid lowering drugs. Hypertension was defined as self-reported doctor's diagnosis, use of
hypertensive medications, systolic blood pressure >140 mmHg or diastolic blood pressure
≥90 mmHg. Myocardial infarction was defined as self-reported history of myocardial
infarction or evidence on ECG of possible or probable myocardial infarction. Diabetes
mellitus was defined as a self-reported doctor's diagnosis, use of diabetes-related
medications or fasting blood glucose >7 mmol/L. The diagnosis of heart failure was based
on hospital discharge diagnosis codes from all hospitals in Reykjavik. Presence of cerebral
infarcts was determined with brain MRI (see below).
MRI Image Acquisition and Image Processing
All participants without contraindications were eligible for a brain MRI performed on a
study-dedicated 1.5-T Signa Twinspeed system (General Electric Medical Systems). The
AGES-Reykjavik MRI image protocol has previously been described in detail (15). In brief,
the protocol included a T1-weighted 3-dimensional spoiled gradient echo sequence, a proton
density/T2-weighted fast-spin echo sequence, a T2*-weighted gradient echo-type echo
planar imaging sequence, and a T2-weighted fluid-attenuated inversion recovery (FLAIR)
sequence. All images were acquired to give full brain coverage in the oblique-axial plane.
The T1- and proton density/T2-weighted images were acquired to include the entire skull,
inferiorly form the level of the foramen magnum. Brain tissue volumes including
cerebrospinal fluid gray matter, white matter and white matter hyperintensities (WMH) were
computed with an automatic image analysis pipeline (The AGES/MNI pipeline), which is
based on the MNI pipeline and optimized for use in the AGES-Reykjavik Study (16). Total
brain volume was computed as the sum of gray matter, white matter and WMH volumes.
The intra-cranial volume was computed as the sum of total brain and cerebrospinal fluid
volumes. The AGES/MNI pipeline has been validated and described in detail elsewhere
(17). All brain volumes are presented as percentages of intracranial volume to correct for
cranial size. All references to brain volume in Results and Discussion relate to brain volume
relative to intracranial volume. Absolute brain volumes are presented in supplemental data
(please see http://stroke.ahajournals.org).
The scoring of cerebral infarcts is described in detail elsewhere (18). Infarcts were scored by
trained radiographers and defined as defects of the brain parenchyma with a signal intensity
that was isotense to that of the cerebrospinal fluid on all pulse sequences and had associated
hyperintensity on FLAIR images with a minimal diameter of 4 mm, except for infarcts in the
cerebellum and brain stem which had no size criteria and did not require associated
hyperintensity. Infarcts with cortical involvement had also no size criteria. The average
inter-rater reliability (weighted kappa) was 0.7 for cerebral infarcts and the intra-rater
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reliability score was 0.9, in 5% of all scans re-read without knowledge of the previous
reading.
Assessment of Cognitive Function
The battery of cognitive tests included multiple tests of 3 cognitive domains. Similar to other
population-based studies, composites scores for memory (MEM), processing speed (SP) and
executive function (EF) were constructed based on a theoretical grouping of tests. The MEM
composite included the immediate and delayed recall of a modified version of the California
Verbal Learning Test (19). The SP composite included the Digit Symbol Substitution Test,
Figure Comparison Test, and the Stroop Test part 1 and 2 (20-22). The EF composite
included the Digits Backward test, a shortened version of the Spatial Working Memory
subtest of the Cambridge Neuropsychological Test Automated Battery, and the Stroop Test
part 3 (21-23). Gender-specific composite measures were computed by converting raw
scores on each test to standardized Z-scores separately by gender and averaging the Z-scores
across the tests in each composite (18). Inter-rater reliability for all tests was excellent
(Spearman correlations range, 0.96–0.99). Ascertainment of dementia was performed in a 3-
step process that has been described elsewhere (12). Briefly, a consensus diagnosis of
dementia based on Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition,
guidelines was made by a panel that included a geriatrician, a neurologist, a
neuropsychologist, and a neuroradiologist taking into account neuropsychological data, MRI
of the brain, a neurological exam and information from interviews of proxies about medical
history and social, cognitive, and daily functioning relevant to the diagnosis.
Statistical Analyses
General characteristics and cardiovascular risk factors were compared among participants
with and without AF with analysis of covariance for continuous outcomes and logistic
regression for categorical outcomes. Analysis of covariance was used to assess the
association between AF and each brain MRI measure and the three cognitive composite
scores. Adjustment for covariates was done in two steps: basic model (age, sex and
education) and multivariable model (basic model + the previously described demographic
and cardiovascular risk factors and presence of cerebral infarcts). To assess if the association
between AF and each cognitive composite score was mediated by brain volume we adjusted
the multivariable model for each brain MRI measure. The association of duration of AF
(divided into tertiles) and type of AF (paroxysmal versus persistent/permanent) was then
assessed. WMH volume was highly skewed so the measure was log-transformed. The means
of WMH volumes are reported as anti-logs.
In secondary analyses we assessed for effect modification of cerebral infarcts by including
interaction terms in the multivariable model. We also checked for effect modification of
anticoagulation use by adding current use of warfarin as a covariate to the multivariable
model and including interaction terms. Significance was set at p<0.05 for all models. All
analyses were performed using SAS version 9.2 (SAS Institute Inc, Cary, NC).
Analytical Sample
Of the 5764 participants of the AGES-Reykjavik study, 5706 gave informed consent to
match the study data to the hospital and the private physician's records. Of these 4569 had
brain MRI scans from which brain volumes could be computed. Demented participants and
those where information on cognitive status was missing were then excluded, leaving 4251
subjects. A subgroup of 3960 had all three cognitive domain test composite scores.
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Results
Characteristics of the cohort
Of the 4251 participants, 330 had a diagnosis of AF. Compared to those without AF,
participants with AF were older, more often male, consumed more alcohol, were more often
on warfarin and had a higher prevalence of hypertension, previous myocardial infarction,
heart failure, diabetes mellitus and cerebral infarcts on MRI (Table 1). AF was paroxysmal
in 41.8% (n=138) of cases and persistent/permanent in 58.2% (n=192). The date of first
diagnosis of AF could be confirmed for 315 of 330 cases. The mean duration of AF was 7.6
± 7.0 years (median value 6.0 years, range 0 to 41 years).
Brain volumes and AF
In the basic model AF was associated with lower volume of total brain, gray matter and
white matter and higher volume of WMH (expressed as a percentage of total intracranial
volume) (Table 2). After adjusting for further potential confounders, these associations
remained significant except for WMH volume (absolute brain volumes are presented in
supplemental table 1, please see http://stroke.ahajournals.org). There was a significant
difference in total brain and gray matter volume depending on the type of AF, as those with
persistent/permanent AF had lower volumes than those with paroxysmal AF (Figure 1 and
table 3). There was a linear trend between increased time since first diagnosis of AF and
lower total brain and gray matter volume (Table 4).
In secondary analysis neither cerebral infarcts nor current warfarin therapy modified the
association between AF and the brain volumes (data not shown)
Tests of Cognitive Function and AF
Participants with AF scored lower on tests of all three cognitive domains: MEM, SP and EF.
After adjusting for cardiovascular risk factors and cerebral infarcts, AF was no longer
significantly associated with SP or EF but the association between AF and MEM remained
largely unchanged (Table 5). Finally the association between AF and MEM was no longer
significant when we added to the models total brain and separately gray matter volume
corrected for total intracranial volume (data not shown). There was no significant difference
in any of the cognitive scores depending on the type of AF. Increased time since the first
diagnosis of AF was associated with lower scores on test of MEM (ptrend = 0.045 for tertiles
of AF duration). There was no significant interaction between cerebral infarcts and AF in
their relation to MEM, SP or EF. Similarly current warfarin therapy was not a significant
interaction factor (data not shown).
Discussion
In this large cross sectional study of non-demented elderly individuals in the general
population we found a significant association between AF and lower total brain, gray and
white matter volume. For both total brain and gray matter volume the association was
stronger with persistent/permanent compared to paroxysmal AF, and with increased time
from first diagnosis of AF, suggesting a cumulative effect. In tests of cognitive function
participants with AF scored significantly lower on tests of memory. As with brain volume,
longer duration of AF was associated with worse outcome. These findings remained
significant even after adjusting for the higher prevalence of cardiovascular risk factors and
cerebral infarcts in AF population. The difference in total brain volume between individuals
with and without AF equals a year and a half of normal loss of brain volume (17).
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Atrial fibrillation and brain volume
Only a few previous studies have examined AF and brain volume. In a study published from
the Cardiovascular Health Study on 303 adults 65-95 years of age, there was not a
significant relation between AF and markers of total brain atrophy (7). However, as the
authors point out, the relatively small sized study may have been underpowered to detect
any association. A study from the Framingham Offspring Study on 1841 individuals did not
find a significant association between AF and total brain volume (8). Similarly, in a recent
case-control study, Knecht et al found no significant difference in total brain volume
between those with and without AF (9). In both of these studies the average age of the
cohort was around ten years younger than in the current study. As mentioned before we
found a linear trend between increased duration of AF and lower total brain volume, i.e. the
effect may be cumulative with increased AF burden. This may explain the lack of
association between AF and total brain volume in younger cohorts.
Atrial fibrillation and cognitive function
After controlling for vascular factors, AF was associated with MEM but not with EP or SP.
The latter two cognitive domains are closely associated with sub-cortical vascular disease
that manifests primarily as infarcts and WMH (24). Those having AF for the longest time
scored the lowest on tests of MEM. There was a trend towards lower scores in those with
persistent/permanent compared to paroxysmal AF but it did not reach statistical significance.
In the Framingham Offspring study on men free of symptoms of stroke, AF was associated
with lower scores on a number of cognitive tests, mainly on SP and EF rather than memory
(5). No adjustment was made for silent cerebral infarcts and, as previously mentioned, this
pattern of cognitive performance is more consistent with subcortical vascular disease. In the
previously mentioned study by Knecht et al, that included 87 patients with AF, all
participants were free of cerebral infarcts on MRI and, similar to the results of the current
study, AF had the strongest association with memory (9).
Potential mechanisms for the associations observed
The association between AF and brain atrophy and lower performance on tests of memory
could only partially be explained by increased comorbidity and cerebral infarcts in the AF
population. One possible explanation is that AF causes multiple microembolisms to the
brain causing microinfarcts and subsequent atrophy. Additionally, altered cerebral blood
perfusion, due to beat to beat variation in stroke volume, may also play a part. Cerebral
hypoperfusion is associated with a reduction in both the gray and white matter volume of the
brain. It however appears to have a greater negative effect on the gray matter, which could
reflect the higher metabolic demand of the gray matter (25-26). We did find a stronger
association between AF and lower gray matter than white matter and this finding may
support the cerebral hypoperfusion hypothesis. There is some limited data on AF and
cerebral blood flow. A small study on patients with no clinical symptoms of heart failure
showed that those with AF had reduced regional cerebral blood flow compared to controls
(27). In addition cerebral blood flow seems to increase after electrical cardioversion of AF
(28). These observations might suggest that patients with persistent/permanent AF have on
average less cerebral perfusion than those with only paroxysmal bursts of AF. We found that
those with persistent/permanent AF had lower total brain and gray matter volume compared
to with paroxysmal AF. It is, however, speculative that maintaining sinus rhythm could have
an impact on the progress of brain atrophy and sequential cognitive decline in patients with
AF. There are data, albeit limited, supporting this speculation. An observational study
demonstrated that those who underwent radiofrequency ablation therapy for AF, which
currently offers the most superior available rhythm control therapy for AF, had significantly
lower risk for dementia than patients who did not have an ablation (29). The incidence of
dementia in those undergoing ablation was similar to those without AF. Cognitive decline
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and brain atrophy need to be considered as endpoints in future prospective studies on
treatment outcomes for AF.
Strength and limitations of the study
The main strength of this study is the large number of well described community dwelling
subjects. This study also has some limitations. As this was a cross-sectional analysis any
inference on direct cause and effect cannot be made. We did not have sufficient information
on ejection fraction or stroke volume to include it as a covariate since echocardiography was
performed on a proportion of the AGES-Reykjavik study cohort (30). Recently subclinical
reductions in cardiac output have been associated with less total brain volume (31).
However controlling for previous clinical diagnosis of heart failure did not affect the main
conclusions of this study. Whether participants had paroxysmal or persistent/permanent AF
was determined at the time of the study examination. We however did not have sufficient
information on frequency or length of previous episodes of AF. This is a limitation in our
ability to fully assess the actual burden of AF. In general individuals with AF are older, have
increased co-morbidities and may more often have implanted cardiac electronic devices.
This might have led to a selection bias in the study, if a higher percentage of persons with
AF declined to participate in the study or could not undergo the brain MRI. As such, the
results may actually underestimate the association between AF and brain volumes and
cognition.
Conclusions
In the general elderly population, AF is associated with lower total brain volume
independent of cerebral infarcts. The association is stronger for persistent/permanent AF
than paroxysmal and with increased duration of the disease, suggesting a cumulative effect.
The difference is evident both in the gray and white matter of the brain. Future prospective
studies are needed to determine if maintenance of sinus rhythm is of benefit to attenuate
brain atrophy and impaired memory performance.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Figure 1.
Mean brain volume expressed as percentage of total intracranial volume (with standard error
bars) in individuals without atrial fibrillation (AF), with paroxysmal AF and with persistent/
permanent AF. Adjusted for age, sex, education level, hypertension, myocardial infarction,
diabetes mellitus, heart failure, smoking, alcohol consumption, hypercholesterolemia, body
mass index, height and cerebral infarcts on magnetic resonance imaging
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Table 1
Characteristics of the study cohort by presence of atrial fibrillation (AF) Data are shown as mean (standard
deviation) for continuous variables and percentages for categorical variables.
No AF (n= 3921) AF (n= 330)
Age, years 75.9 (5.3) 78.0 (5.4) ‡
Gender, % men 39.8 62.4†
Education, % primary 22.9 18.2
MMSE 27.1 (2.4) 26.6 (2.5)
Body mass index 27.0 (4.3) 27.1 (4.4)
Height, centimeters 166.8 (9.2) 170.9 (10.1) ‡
Ever smoker 56.7 63.9
Alcohol consumption, moderate/high 1.3 4.3†
Depressive symptoms 6.5 6.4
Hypertension 79.3 91.5‡
Myocardial infarction 13.6 23.9†
Heart failure 1.6 14.9‡
Diabetes mellitus 10.6 15.2*
Hypercholesterolemia 57.6 48.8
Warfarin use 1.9 46.4‡
Cerebral infarct on MRI 28.6 48.8‡
*P < 0.05;
†P < 0.01,
‡P < 0.001 for age- and sex-adjusted comparison
MMSE = mini mental state examination
MRI = magnetic resonance imaging
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Table 2
Association between atrial fibrillation (AF) and MRI measured brain volumes: the
AGES-Reykjavik Study
No AF AF
Total brain volume
 Unadjusted 72.4 (72.3-72.5) 70.2 (69.8-70.6) ‡
 Model 1a 72.1 (72.0-72.2) 71.0 (70.6-71.4) ‡
 Model 2 b 70.2 (69.7-70.8) 69.4 (68.8-70.0) ‡
Gray matter volume
 Unadjusted 45.3 (45.2-45.4) 43.5 (43.2-43.9)‡
 Model 1a 45.1 (45.0-45.2) 44.2 (43.9-44.5) ‡
 Model 2 b 43.7 (43.2-44.1) 43.0 (42.5-43.5) ‡
White matter volume
 Unadjusted 25.8 (25.7-25.8) 25.0 (24.8-25.2) ‡
 Model 1a 25.7 (25.7-25.8) 25.3 (25.1-25.5) ‡
 Model 2 b 25.2 (25.0-25.5) 25.0 (24.7-25.3) †
WMH volume
 Unadjusted 0.88 (0.86-0.91) 1.09 (0.99-1.20) ‡
 Model 1a 0.89 (0.87-0.99) 0.99(0.90-1.09) *
 Model 2 b 0.96 (0.84-1.10) 1.00 (0.86-1.16)
Data are adjusted mean percentage of total intracranial volume (95% confidence interval). Comparison to no AF:
*P<0.05,
†P<0.01,
‡P<0.001
a
Model 1: adjustedforage,sexandeducationlevel
b
Model 2: adjusted for age, sex, education level, body mass index, height, smoking, alcohol comsumption, hypercholesterolemia, hypertension,
diabetes mellitus, myocardial infarction and heart failure and cerebral infarcts on MRI
WMH = white matter hyperintesities
MRI = magnetic resonance imaging
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Table 3
Association between types of atrial fibrillation (AF) and MRI measured brain volumes:
The AGES-Reykjavik Study
Paroxysmal AF Persistent/permanent AF
Gray matter volume -0.31 (0.24)
-0.96 (0.21) *
White matter volume -0.11 (0.15) -0.38 (0.13)
WMH volume 0.03 (0.06) 0.05 (0.08)
Total brain volume -0.34 (0.29)
-1.20 (0.25) *
Data are differences in brain volume expressed as percentage of total intracranial volume (standard error) in comparison to no AF
Paroxysmal compared to persistent/permanent AF:
*P<0.05,
†P<0.01,
‡P<0.001
Model is adjusted for age, sex, education, hypertension, myocardial infarction, diabetes mellitus, heart failure, smoking, alcohol use,
hypercholesterolemia, body mass index, height and cerebral infarcts on MRI.
WMH = white matter hyperintesities
MRI = magnetic resonance imaging
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Table 4
Association between duration of atrial fibrillation (AF) by tertile and MRI measured
brain volumes: The AGES-Reykjavik Study
Duration of AF Total brain volume Gray matter volume White matter volume
No AF (ref) 70.2 43.7 25.2
1 69.5* 43.1* 25.0
2 69.4* 42.9† 24.9*
3 69.3† 43.0† 25.0
P for linear trend 0.012 0.011 0.16
Data are adjusted mean percentage of total intracranial volume, adjusted for age, sex, education level, hypertension, myocardial infarction, diabetes
mellitus, heart failure, smoking, alcohol use, hypercholesterolemia, body mass index, height and cerebral infarcts on MRI. For tertiles of AF
duration the values are < 3.7 years for tertile 1 (n= 105), 3.7 – 8.6 years for tertile 2 (n=105) and > 8.6 years for tertile 3 (n=105). Comparison to no
AF:
*P<0.05,
†P<0.01,
‡P<0.001
MRI = magnetic resonance imaging
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Table 5
Association between atrial fibrillation (AF) and cognitive domains (z scores): The AGES-
Reykjavik Study
Model 1a Model 2 b
Memory
-0.10 (0.05)* -0.10 (0.05)*
SP -0.06 (0.04) -0.03 (0.04)
EF
-0.07 (0.04)* -0.05 (0.04)
Data are differences in adjusted means of composite scores for cognitive domains (standard error) in comparison to no AF
Comparison to no AF:
*P < 0.05,
†P < 0.01,
‡P < 0.001.
a
Model 1: adjusted for age, sex and education level
b
Model 2: adjusted for age, sex, education level, depressive symptoms, hypertension, myocardial infarction, diabetes mellitus, heart failure,
smoking, body mass index, alcohol consumption, hypercholesterolemia and cerebral infarcts on MRI
MRI = magnetic resonance imaging
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